Santhera Pharmaceuticals Holding(CH:SANN)
CHF 13.64-0.16 (-1.16%)
CH:SANN
Santhera Pharmaceuticals Holding earnings date
CHF 13.64
At close:-0.16 (-1.16%)
Want to see CH:SANN full AI Analyst Report?
Santhera Pharmaceuticals Holding (SANN) Q2 2025 Earnings Report
6 Followers
CH:SANN Q2 2025 EPS Results
- Actual EPS
- -CHF 3.04
- Consensus EPS
- -CHF 0.60
- Beat/Miss
- Missed by -CHF 2.44
- One Year Ago EPS
- -CHF 1.35
CH:SANN Q2 2025 Revenue Results
- Actual Revenue
- CHF 24.01M
- Expected Revenue
- CHF 12.00M
- Beat/Miss
- Beat by +CHF 12.01M
- YoY Revenue Growth
- +70.14%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 09/23/2025
- Time
- Before Open
- Conference Call
- Tuesday, September 23, 2025
CH:SANN Upcoming Earnings
Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
CH:SANN Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:SANN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 29, 2027 | 2026 (Q4) | ―- | -0.43 | ― | ― |
| Sep 30, 2026 | 2026 (Q2) | 0.17-1.50 | -0.37 | -305.41% (-1.13) | |
| Apr 28, 2026 | 2025 (Q4) | -0.43-0.43 | -0.74 | 41.89% (+0.31) | |
| Sep 23, 2025 | 2025 (Q2) | -0.60-3.04 | -1.35 | -125.19% (-1.69) | |
| Apr 29, 2025 | 2024 (Q4) | -0.74-0.74 | 7.27 | -110.18% (-8.01) | |
| Sep 12, 2024 | 2024 (Q2) | -0.94-1.35 | -1.58 | 14.56% (+0.23) | |
| Apr 25, 2024 | 2023 (Q4) | ―7.27 | -2.13 | 441.31% (+9.40) | |
| Sep 07, 2023 | 2023 (Q2) | -1.58-1.58 | -5.24 | 69.85% (+3.66) | |
| Apr 27, 2023 | 2022 (Q4) | ―-2.13 | -2.3 | 7.39% (+0.17) | |
| Oct 31, 2022 | 2022 (Q2) | ―-5.24 | -9.22 | 43.19% (+3.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


